About Us

Resolution Biomedical, Inc (“RBI”) was founded in 2009 to develop and sell and innovative liquid-based cytology system for cervical cancer screening. Over 75 million Pap tests are performed each year in the U.S. and more than 170 million worldwide. However, the disease is still the second most common cancer in women worldwide, with more than 300,000 deaths annually.